Latest | F'cast | |
---|---|---|
Div Yield | 0.9% | 0.0% |
Div Cover | n/a | 2.6 |
Op Mrgn | n/a | 27.5% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 39.6 | 9.2 |
PEG | n/a | n/a |
Pr/Revenue | 9.6 | 1.9 |
Pr/Book | 5.3 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | 325.2% |
PBT | 7.7% | 535.0% |
EPS | n/a | 0.9% |
DPS | n/a | 301.2% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 33,754.00 | 6,221.00 | 123.90p | 17.9 | 4.5 | +4% | 80.00p | 3.6% |
31-Dec-20 | 34,099.00 | 6,968.00 | 115.90p | 14.5 | n/a | -6% | 80.00p | 4.8% |
31-Dec-21 | 24,696.00 | 3,599.00 | 90.56p | 22.2 | n/a | -22% | 80.00p | 4.0% |
31-Dec-22 | 29,324.00 | 5,628.00 | 139.70p | 10.3 | 0.2 | +54% | 44.00p | 3.1% |
31-Dec-23 | 30,328.00 | 6,064.00 | 155.10p | 9.4 | 0.9 | +11% | 42.00p | 2.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 31,304.73 | 8,604.84 | 156.55p | 8.9 | 9.5 | +1% | 60.19p | 0.0% |
31-Dec-25 | 32,633.03 | 9,480.58 | 170.24p | 8.2 | 0.9 | +9% | 64.06p | 0.0% |
31-Dec-26 | 34,504.68 | 10,531.79 | 188.64p | 7.4 | 0.7 | +11% | 68.34p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Total Voting Rights | 01-Nov-2024 | 15:00 | RNS |
Director/PDMR Shareholding | 30-Oct-2024 | 14:29 | RNS |
3rd Quarter Results | 30-Oct-2024 | 07:00 | RNS |
GSK offsets vaccine losses with new drugs for ca... | 30-Oct-2024 | Times |
GSK under pressure over key vaccines | 28-Oct-2024 | Times |
GlaxoSmithKline scraps sale of old drugs | 05-Dec-2014 | Telegraph |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Oct-24 | Buy | Jonathan Symonds | 1,393.65p | 7,150 | £99,645.97 |
15-Oct-24 | Buy Dividends | Julie Brown | 1,505.00p | 571 | £8,593.55 |
15-Oct-24 | Buy Dividends | Hal Barron | 2,999.40p | 431 | £12,927.43 |
Currency | UK Pounds |
Share Price | 1,391.50p |
Change Today | -22.50p |
% Change | -1.59 % |
52 Week High | 1,812.50 |
52 Week Low | 1,382.00 |
Volume | 4,813,085 |
Shares Issued | 4,145.10m |
Market Cap | £57,679m |
RiskGrade | 129 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 4 |
Neutral | 10 |
Sell | 2 |
Strong Sell | 0 |
Total | 24 |
Latest | Previous | |
---|---|---|
Q3 | Q2 | |
Ex-Div | 15-Nov-24 | 15-Aug-24 |
Paid | 09-Jan-25 | 10-Oct-24 |
Amount | 15.00p | 15.00p |
Time | Volume / Share Price |
16:48 | 912 @ 1,391.50p |
16:48 | 3,112 @ 1,391.50p |
16:47 | 3,242 @ 1,389.60p |
16:47 | 27,245 @ 1,399.17p |
16:46 | 1,146 @ 1,391.50p |
You are here: research